You are here

Treatments

Problem: Unapproved stem-cell therapies are being marketed to people with long COVID

New research has identified 38 direct-to-consumer businesses marketing stem-cell treatments and exosome therapies for COVID-19 infections and, especially, long COVID, despite lacking approval by US Food and Drug Administration and other regulatory body in the United States. Descriptions of the businesses and an analysis of their marketing strategies are published in Stem Cell Reports.

...

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Beyfortus drug to protect infants from RSV is in short supply--CDC warns

 

... The agency told doctors to prioritize getting those doses to infants at the highest risk of severe RSV, including infants younger than 6 months and those with underlying conditions. The CDC also advised doctors to preserve 50 mg doses for infants who weigh less than 11 pounds.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pre-pandemic efficiently managed hospital ICU's had lower COVID-19 deaths --study

... in Chest, a review of intensive care units (ICUs) across 10 Brazilian states shows that those with lower mortality rates pre-pandemic saw lower COVID-19 death rates.

Moreover, efficiently managed ICUs also saw lower mortality from the novel coronavirus, suggesting that hospital management is directly linked to patient outcomes.

...

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Drug prices: Major drugmakers agree to negotiate drug prices with U.S. government

Major drug companies including Johnson & Johnson, Merck and Bristol Myers Squibb have committed to participate in Medicare drug price negotiations with the federal government, the Biden administration said Tuesday.

...

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Treatments
howdy folks